276 related articles for article (PubMed ID: 3196692)
1. Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.
Ged C; Umbenhauer DR; Bellew TM; Bork RW; Srivastava PK; Shinriki N; Lloyd RS; Guengerich FP
Biochemistry; 1988 Sep; 27(18):6929-40. PubMed ID: 3196692
[TBL] [Abstract][Full Text] [Related]
2. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.
Shimada T; Misono KS; Guengerich FP
J Biol Chem; 1986 Jan; 261(2):909-21. PubMed ID: 3079764
[TBL] [Abstract][Full Text] [Related]
3. Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase.
Umbenhauer DR; Martin MV; Lloyd RS; Guengerich FP
Biochemistry; 1987 Feb; 26(4):1094-9. PubMed ID: 3032244
[TBL] [Abstract][Full Text] [Related]
4. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
Srivastava PK; Yun CH; Beaune PH; Ged C; Guengerich FP
Mol Pharmacol; 1991 Jul; 40(1):69-79. PubMed ID: 1857342
[TBL] [Abstract][Full Text] [Related]
5. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.
Brian WR; Srivastava PK; Umbenhauer DR; Lloyd RS; Guengerich FP
Biochemistry; 1989 Jun; 28(12):4993-9. PubMed ID: 2669966
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of human cytochrome P-450.
Guengerich FP; Umbenhauer DR; Churchill PF; Beaune PH; Böcker R; Knodell RG; Martin MV; Lloyd RS
Xenobiotica; 1987 Mar; 17(3):311-6. PubMed ID: 3577206
[TBL] [Abstract][Full Text] [Related]
7. Cloning of human cytochrome P-450 cDNA and its expression in Saccharomyces cerevisiae.
Ohgiya S; Komori M; Fujitani T; Miura T; Shinriki N; Kamataki T
Biochem Int; 1989 Feb; 18(2):429-38. PubMed ID: 2669757
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily.
Romkes M; Faletto MB; Blaisdell JA; Raucy JL; Goldstein JA
Biochemistry; 1991 Apr; 30(13):3247-55. PubMed ID: 2009263
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency.
Meier UT; Meyer UA
Biochemistry; 1987 Dec; 26(25):8466-74. PubMed ID: 3442670
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
11. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans.
Goldstein JA; Faletto MB; Romkes-Sparks M; Sullivan T; Kitareewan S; Raucy JL; Lasker JM; Ghanayem BI
Biochemistry; 1994 Feb; 33(7):1743-52. PubMed ID: 8110777
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity.
Bork RW; Muto T; Beaune PH; Srivastava PK; Lloyd RS; Guengerich FP
J Biol Chem; 1989 Jan; 264(2):910-9. PubMed ID: 2463251
[TBL] [Abstract][Full Text] [Related]
13. 5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.
Shu Y; Wang LS; Xu ZH; He N; Xiao WM; Wang W; Huang SL; Zhou HH
J Pharmacol Exp Ther; 2000 Nov; 295(2):844-51. PubMed ID: 11046127
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.
Aoyama T; Yamano S; Waxman DJ; Lapenson DP; Meyer UA; Fischer V; Tyndale R; Inaba T; Kalow W; Gelboin HV
J Biol Chem; 1989 Jun; 264(18):10388-95. PubMed ID: 2732228
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450 human-2 (P-450IIC9) in mephenytoin hydroxylation polymorphism in human livers: differences in substrate and stereoselectivities among microheterogeneous P-450IIC species expressed in yeasts.
Yasumori T; Yamazoe Y; Kato R
J Biochem; 1991 May; 109(5):711-7. PubMed ID: 1917894
[TBL] [Abstract][Full Text] [Related]
16. Partial sequence and polymerase chain reaction-mediated analysis of expression of the human CYP2C18 gene.
Ged C; Beaune P
Pharmacogenetics; 1992 Jun; 2(3):109-15. PubMed ID: 1306110
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form.
Yasumori T; Kawano S; Nagata K; Shimada M; Yamazoe Y; Kato R
J Biochem; 1987 Nov; 102(5):1075-82. PubMed ID: 2963808
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.
Ohmori S; Chiba K; Nakasa H; Horie T; Kitada M
Arch Biochem Biophys; 1994 Jun; 311(2):395-401. PubMed ID: 8203903
[TBL] [Abstract][Full Text] [Related]
19. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.
Yamano S; Tatsuno J; Gonzalez FJ
Biochemistry; 1990 Feb; 29(5):1322-9. PubMed ID: 2322567
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.
Kobayashi K; Kogo M; Tani M; Shimada N; Ishizaki T; Numazawa S; Yoshida T; Yamamoto T; Kuroiwa Y; Chiba K
Drug Metab Dispos; 2001 Jan; 29(1):36-40. PubMed ID: 11124227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
